Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of GRT7014 vs Norco in Healthy Adults
NCT03137030Phase 1Withdrawn
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydrocodone and acetaminophen in pain and opioid use disorder (OUD) (4 arms), sponsored by Grünenthal GmbH. Primary endpoints: Maximum Plasma Concentration, Area Under the Plasma Concentration Curve from Time 0 to t and 1 more. Planned start Sep 2017; status: withdrawn.
02
Drugs
hydrocodoneacetaminophen
03
Conditions
painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03137030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137030.